Angiogenesis in mucous retention cyst: A human in vivo-like model of endothelial cell differentiation in mucous substrate

Journal of Oral Pathology and Medicine

Volumn 34, Issue 1, 2005, Pages 30-38

  Swelam, Wael ^a   Ida Yonemochi, Hiroko ^a   Saku, Takashi ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

Author keywords

Angiogenesis; CD31; CD34; Endothelial progenitor; Flk 1; Mucous retention cyst; Tenascin; Vascular endothelial growth factor

Indexed keywords

BIOLOGICAL MARKER; CD31 ANTIGEN; CD34 ANTIGEN; CD68 ANTIGEN; MESSENGER RNA; TENASCIN; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2; VON WILLEBRAND FACTOR;

ANGIOGENESIS; ARTICLE; CAPILLARY; CELL DIFFERENTIATION; CELL LINEAGE; CELL STRUCTURE; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; IN VIVO STUDY; MACROPHAGE; MAJOR CLINICAL STUDY; MODEL; MONOCYTE; MUCOCELE; MUCUS; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM;

ANTIGENS, CD; ANTIGENS, CD31; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LIP DISEASES; MUCOCELE; NEOVASCULARIZATION, PATHOLOGIC; TENASCIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 12444344810     PISSN: 09042512     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2004.00282.x     Document Type: Article

References (37)

1. Djonov V, Baum O, Burri PH. Vascular remodeling by intussusceptive angiogenesis. Cell Tissue Res 2003; 314: 107-17.
2. Veikkola T, Alitalo K. VEGFs, receptors and angiogenesis. Semin Cancer Biol 1999; 9: 211-20.
3. Asahara T, Masuda H, Takahashi T, et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 1999; 85: 221-8.
4. Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997; 275: 964-7.
5. Akeson AL, Brooks SK, Thompson FY, Greenberg JM. In vitro model for developmental progression from vasculogenesis to angiogenesis with a murine endothelial precursor cell line, MFLM-4. Microvasc Res 2001; 61: 75-86.
6. Asahara T, Takahashi T, Masuda H, et al. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J 1999; 18: 3964-72.
7. Rosenstein JM, Mani N, Silverman WF, Krum JM. Patterns of brain angiogenesis after vascular endothelial growth factor administration in vitro and in vivo. Proc Natl Acad Sci USA 1998; 95: 7086-91.
8. Alessandri G, Girelli M, Taccagni G, et al. Human vasculogenesis ex vivo: embryonal aorta as a tool for isolation of endothelial cell progenitors. Lab Invest 2001; 81: 875-85.
9. Peters KG, Vries CD, Williams LT. Vascular endothelial growth factor receptor expression during embryogenesis and tissue repair suggests a role in endothelial differentiation and blood vessel growth. Proc Natl Acad Sci USA 1993; 90: 8915-9.
10. Nakayasu K. Origin of pericytes in neovascularization of rat cornea. Jpn J Ophthalmol 1988; 32: 105-12.
11. Sholley MM, Ferguson GP, Seibel HR, Montour JL, Wilson JD. Mechanisms of neovascularization. Vascular sprout can occur without proliferation of endothelial cells. Lab Invest 1984; 51: 624-34.
12. Seifert G, Miehlke A, Haubrich J, Chilla R. Diseases of the salivary glands. Stuttgart: Georg Thieme Verlag, 1986;91-8.
13. Shear M. Cysts of the oral regions. 3rd edn. Oxford, UK: Wright, 1992; 212-21.
14. Regezi JA, Sciubba JJ, Jordan RCK. Oral pathology: clinical pathologic correlations. 4th edn. Philadelphia, USA: W.B. Saunders Company, 2003; 183-7.
15. Metwaly H, Cheng J, Ida-Yonemochi H, et al. Vascular endothelial cell participation in formation of lymphoepithelial lesions (epi-myoepithelial islands) in lymphoepithelial sialadenitis (benign lymphoepithelial lesion). Virchows Arch 2003; 443: 17-27.
16. Schmeisser A, Garlichs CD, Zhang H, et al. Monocytes coexpress endothelial and macrophagocytic lineage markers and form cord-like structures in matrigel under angiogenic conditions. Cardiovasc Res 2001; 49: 671-80.
17. Roni V, Habeler W, Parenti A, et al. Recruitment of human umbilical vein endothelial cells and human primary fibroblasts into experimental tumors growing in SCID mice. Exp Cell Res 2003; 287: 28-38.
18. Campochiaro PA, Hackett SF. Ocular neovascularization: a valuable model system. Oncogene 2003; 22: 6537-48.
19. Folkman J. Incipient angiogenesis. J Natl Cancer Inst 2000; 92: 94-5.
20. Folkman J, Haudenschild C. Angiogenesis in vitro. Nature 1980; 288: 551-6.
21. Gerhardt H, Golding M, Fruttiger M, et al. VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J Cell Biol 2003; 161: 1163-77.
22. Shalaby F, Rossant J, Yamaguchi TP, et al. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 1995; 376: 62-6.
23. - hematopoietic and mesenchymal stem cells from various sources. Stem Cells 2000; 18: 1-9.
24. Eggermann J, Kliche S, Jarmy G, et al. Endothelial progenitor cell culture and differentiation in vitro: a methodological comparison using human umbilical cord blood. Cardiovasc Res 2003; 58: 478-86.
25. Suster S, Wong TY. On the discriminatory value of anti-HPCA-1 (CD34) in the differential diagnosis of benign and malignant cutaneous vascular proliferations. Am J Dermatopathol 1994; 16: 355-63.
26. -: which is the more primitive? Leukemia 2002; 16: 1603-8.
27. Pammer J, Weninger W, Mildner M, Burian M, Wojta J, Tschachler E. Vascular endothelial growth factor is constitutively expressed in normal human salivary glands and is secreted in the saliva of healthy individuals. J Pathol 1998; 186: 186-91.
28. Taichman NS, Cruchley AT, Fletcher LM, et al. Vascular endothelial growth factor in normal human salivary glands and saliva: a possible role in the maintenance of mucosal homeostasis. Lab Invest 1998; 78: 869-75.
29. Josko J, Gwozdz B, Jedrzejowska-Szypulka H, Hendryk S. Vascular endothelial growth factor (VEGF) and its effect on angiogenesis. Med Sci Monit 2000; 6: 1047-52.
30. Rogelj S, Klagsbrun M, Atzmon R, et al. Basic fibroblast growth factor is an extracellular matrix component required for supporting the proliferation of vascular endothelial cells and the differentiation of PC 12 cells. J Cell Biol 1989; 109: 823-31.
31. Guo P, Hu B, Gu W, et al. Platelet-derived growth factor-B enhances glioma angiogenesis by stimulating vascular endothelial growth factor expression in tumor endothelia and by promoting pericyte recruitment. Am J Pathol 2003; 162: 1083-93.
32. Zagzag D, Shiff B, Jallo GI, et al. Tenascin-C promotes microvascular cell migration and phosphorylation of focal adhesion kinase. Cancer Res 2002; 62: 2660-8.
33. Schenk S, Chiquet-Ehrismann R, Battegay EJ. The fibrinogen globe of tenascin-C promotes basic fibroblast growth factor-induced endothelial cell elongation. Mol Biol Cell 1999; 10: 2933-43.
34. Marneros AG, Olsen BR. The role of collagen-derived proteolytic fragments in angiogenesis. Matrix Biol 2001; 20: 337-45.
35. Larivière B, Rouleau M, Picard S, Beaulieu AD. Human plasma fibronectin potentiates the mitogenic activity of platelet-derived growth factor and complements its wound healing effects. Wound Rep Reg 2003; 11: 79-89.
36. Scoazec JY, Flejou JF, D'Errico A, et al. Fibrolamellar carcinoma of the liver: composition of the extracellular matrix and expression of cell-matrix and cell-cell adhesion molecules. Hepatology 1996; 24: 1128-36.
37. Clark RA, Erickson HP, Springer TA. Tenascin supports lymphocyte rolling. J Cell Biol 1997; 137: 755-65.